β-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells

Atherosclerosis

Volumn 162, Issue 2, 2002, Pages 307-313

  Takahashi, Masafumi ^a   Takahashi, Sadao ^b   Shimpo, Masahisa ^a   Naito, Akitaka ^a   Ogata, Yukiyo ^a   Kobayashi, Eiji ^a   Ikeda, Uichi ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Interleukin; Lipid; Nitric oxide; Smooth muscle cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 DIMETHYLAMINO 1 PHENYL 6 PYRIDAZONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GENISTEIN; HERBIMYCIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; ISOENZYME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE; NITRITE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; ENZYME INHIBITORS; INTERLEUKIN-1; LIPOPROTEINS; LIPOPROTEINS, VLDL; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0036240706     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00727-4     Document Type: Article

References (30)

1. Nitric oxide: Physiology, pathophysiology, and pharmacology
2. Regulation of biosynthesis of nitric oxide
3. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease
4. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes
5. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets
6. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
7. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils
8. Plasma triglyceride and coronary heart disease
9. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment
10. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
11. Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1
12. Effect of oxidized low density lipoprotein on thrombomodulin expression by THP-1 cells
13. Lowry method of protein quantification: Evidence for photosensitivity
14. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell. I. Chemical modifications of ultraviolet-treated low-density lipoproteins
15. Effects of aspirin-like drugs on nitric oxide synthesis in rat vascular smooth muscle cells
16. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon? and lipopolysaccharide
17. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells
18. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells
19. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
20. Myocardial infarction in the familial forms of hypertriglyceridemia
21. Management of dyslipidemia in NIDDM
22. Very low density and low density lipoproteins induce nitric oxide synthesis in macrophages
23. Induction of microglial nitric oxide synthesis by very low density lipoprotein
24. Low-density lipoprotein-induced formation of nitric oxide by cultured vascular smooth muscle cells of the rat
25. Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits
26. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism
27. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits
28. Interleukin-1β regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes
29. P38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages
30. Overexpression of protein kinase C alpha enhances lipopolysaccharide-induced nitric oxide formation in vascular smooth muscle cells